FrancophonIA/ELRC3.0 huggingface dataset:
English: rifabutin (used to prevent/treat certain infections)*; voriconazole (used to treat fungal infections)*; simvastatin, lovastatin (used to lower blood cholesterol); neratinib (used to treat breast cancer); lomitapide (used to lower blood cholesterol); alfuzosin (used to treat enlarged prostate gland); fusidic acid (used to treat bacterial infections); sildenafil if you suffer from a lung disease called pulmonary arterial hypertension that makes breathing difficult.
Croatian: - ranolazin (lijek za liječenje kronične boli u prsištu [angine]); - petidin, piroksikam, propoksifen (koriste se za ublažavanje boli); - cisaprid (koristi se za uklanjanje određenih želučanih smetnji); - rifabutin (koristi se za sprječavanje/liječenje određenih infekcija)*; - vorikonazol (koristi se za liječenje gljivičnih infekcija)*; - simvastatin, lovastatin (koriste se za snižavanje razina kolesterola u krvi); - neratinib (koristi se u liječenju raka dojke); - lomitapid (upotrebljava se za snižavanje kolesterola u krvi); - alfuzosin (koristi se za liječenje povećane prostate); - fuzidičnu kiselinu (koristi se za liječenje bakterijskih infekcija); - sildenafil, ako imate plućnu bolest koja se naziva plućna arterijska hipertenzija, koja otežava disanje; bolesnici koji nemaju tu bolest mogu, pod liječničkim nadzorom, uzimati sildenafil za liječenje impotencije (erektilna disfunkcija) (pogledajte i dio Drugi lijekovi i
English: 200q12h ↑ 28% ↑ 9% Careful monitoring of therapeutic and adverse effects is recommended when prednisolone is concomitantly administered with ritonavir.
Croatian: 200 svakih 12 h ↑ 28% ↑ 9% Kada se prednizolon daje istodobno s ritonavirom preporučuje se pažljivo praćenje terapijskih učinaka i mogućih nuspojava.
English: 50, single dose 200q12h ↑ 2.4-fold ↑ 34% An increase in the incidence in trazodone-related adverse reactions was noted when co-administered with ritonavir dosed as an antiretroviral agent or as a pharmacokinetic enhancer.
Croatian: 50, jednokratna doza 200 svakih 12 h ↑ 2,4 puta Pri primjeni trazodona istodobno s ritonavirom kao antiretrovirusnim lijekom ili kao farmakokinetičkim pojačivačem zabilježena je povećana učestalost nuspojava povezanih s trazodonom.
English: Ritonavir dosed as a pharmacokinetic enhancer or as an antiretroviral agent induces glucuronidation and as a result is expected to decrease the plasma concentrations of atovaquone.
Croatian: Ritonavir doziran kao antiretrovirusni lijek ili kao farmakokinetički pojačivač inducira glukuronidaciju, zbog čega se očekuje da će smanjiti koncentracije atovakona u plazmi.
English: 100 mg twice daily1
Croatian: 100 dva puta na dan1
English: 200 mg once daily
Croatian: 200 mg jedanput na dan
English: • reduced kidney function
Croatian: • smanjena bubrežna funkcija
English: ↑ 3-7 fold
Croatian: ↑2puta ↑ 3 - 7puta
English: Repeated dose toxicity studies in animals identified major target organs as the liver, retina, thyroid gland and kidney.
Croatian: Ispitivanja toksičnosti opetovanih doza u životinja pokazala su da su glavni ciljni organi jetra, mrežnica, štitnjača i bubrezi.
English: Increased plasma concentrations of ranolazine which may increase the potential for serious and/or life-threatening reactions (see section 4.5).
Croatian: Povećane koncentracije ranolazina u plazmi, što može povećati mogućnost nastupa ozbiljnih i/ili po život opasnih reakcija (vidjeti dio 4.5).
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 100 mg of ritonavir.
Croatian: NAVOĐENJE DJELATNE(IH) TVARI Jedna filmom obložena tableta sadrži 100 mg ritonavira.
English: Fosamprenavir 700 mg twice daily with ritonavir 100 mg twice daily.
Croatian: Fosamprenavir 700 mg dva puta na dan s ritonavirom 100 mg dva puta na dan.
English: Serum concentrations may be increased due to P-glycoprotein, BCRP and OATP1B inhibition by ritonavir.
Croatian: Serumske se koncentracije mogu povećati zbog inhibicijskog učinka ritonavira na P-glikoprotein BCRP i OATP1B.
English: A case of renal failure with eosinophilia has been reported.
Croatian: Prijavljen je slučaj zatajenja bubrega s eozinofilijom.
English: The concomitant administration with ranolazine is contraindicated (see section 4.3).
Croatian: Istodobna primjena s ranolazinom je kontraindicirana (vidjeti dio 4.3).
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Croatian: Lijek se izdaje na ograničeni recept (vidjeti Prilog I: Sažetak opisa svojstava lijeka, dio 4.2.).
English: You must not take Ritonavir Mylan with sildenafil if you suffer from pulmonary arterial hypertension (see also section 2.
Croatian: Ako bolujete od plućne arterijske hipertenzije, Ritonavir Mylan ne smijete uzimati istodobno sa sildenafilom (pogledajte i dio 2.
English: Ritonavir co-administration is likely to result in increased plasma concentrations of clorazepate, diazepam, estazolam and flurazepam and is therefore contraindicated (see section 4.3).
Croatian: Istodobno primijenjeni ritonavir vjerojatno povećava koncentracije klorazepata, diazepama, estazolama i flurazepam u plazmi te je stoga kontraindiciran (vidjeti dio 4.3).
English: Adverse reactions of nausea, dizziness, hypotension and syncope have been observed in single dose interaction studies in healthy volunteers (see section 4.5).
Croatian: U ispitivanjima interakcija pri primjeni jednokratnih doza zdravim dobrovoljcima uočene su nuspojave poput mučnine, omaglice, hipotenzije i sinkope (vidjeti dio 4.5).
English: Anticancer
Croatian: Antituberkulotici
English: Important information regarding medicinal product interactions when ritonavir is used as a pharmacokinetic enhancer is also contained in the Summary of Product Characteristics of the co-administered protease inhibitor.
Croatian: Važne informacije o interakcijama među lijekovima kada se ritonavir daje kao farmakokinetički pojačivač mogu se naći i u Sažetku opisa svojstava lijeka za inhibitor proteaze koji se istodobno primjenjuje.
English: Ritonavir doses higher than 100 mg twice daily have not been studied with fosamprenavir.
Croatian: Ritonavir u dozama većima od 100 mg dva puta na dan nije ispitan u kombinaciji s fosamprenavirom.
English: Caution is warranted during the first several days when alprazolam is co-administered with ritonavir dosed as an antiretroviral agent or as a pharmacokinetic enhancer, before induction of alprazolam metabolism develops.
Croatian: Ako se alprazolam daje istodobno s ritonavirom doziranim kao antiretrovirusnim lijekom ili kao farmakokinetičkim pojačivačem, nužan je oprez tijekom prvih nekoliko dana, dok ne nastupi indukcija metabolizma alprazolama.
English: Abemaciclib
Croatian: Abemaciklib
English: 50 μg, single dose
Croatian: 50 µg, jednokratna doza
English: More frequent electrocardiogram monitoring and monitoring of transaminases is recommended (see section 4.4 and refer to the bedaquiline Summary of Product Characteristics).
Croatian: Preporučuje se učestalije praćenje elektrokardiograma i transaminaza (vidjeti dio 4.4 te Sažetak opisa svojstava lijeka za bedakilin).
English: C-labelled ritonavir in rats showed the liver, adrenals, pancreas, kidneys and thyroid to have the highest concentrations of ritonavir.
Croatian: Ispitivanja distribucije 14C-obilježenog ritonavira po tkivima štakora pokazala su najviše koncentracije ritonavira u jetri, nadbubrežnim žlijezdama, gušterači, bubrezima i štitnjači.
English: ↑ 64% ↑ 5 fold
Croatian: ↑ 15 puta ↑ 5 puta
English: 500 q12 h
Croatian: 500 svakih 12 h
English: Specific recommendations for use of ritonavir as a pharmacokinetic enhancer in patients with hepatic impairment are dependent on the protease inhibitor with which it is co-administered.
Croatian: Specifične preporuke o primjeni ritonavira kao farmakokinetičkog pojačivača u bolesnika s oslabljenom funkcijom jetre ovise o inhibitoru proteaza u kombinaciji s kojim se ritonavir daje.
English: Amprenavir 600 mg twice daily with ritonavir 100 mg twice daily.
Croatian: Amprenavir 600 mg dva puta na dan s ritonavirom 100 mg dva puta na dan.
English: 100q12h ↑ 7.2-fold ↑ 4.7-fold Ritonavir increases plasma concentrations of simeprevir as a result of CYP3A4 inhibition.
Croatian: Fosamprenavir 700 svakih 12 h 100 svakih 12 h Amprenavir ↑ 2,4 puta ↑ 11 puta Ritonavir povisuje serumske razine amprenavira (iz fosamprenavira) zbog inhibicije CYP3A4.
English: For further information, physicians should refer to the Summary of Product Characteristics for tipranavir.
Croatian: Daljnje informacije liječnik treba potražiti u Sažetku opisa svojstava lijeka za tipranavir.
English: Ritonavir must not be given to patients with severe hepatic impairment (see section 4.3).
Croatian: Ritonavir se ne smije davati bolesnicima s jako oslabljenom funkcijom jetre (vidjeti dio 4.3).
English: Increased plasma concentrations of amiodarone, bepridil, dronedarone, encainide, flecainide, propafenone, quinidine.
Croatian: Povećane koncentracije amiodarona, bepridila, dronedarona, enkainida, flekanida, propafenona i kinidina u plazmi.
English: Thereby, increasing the risk of serious arrhythmias from this agent.
Croatian: Time se povećava rizik od ozbiljnih aritmija izazvanih tim lijekom.
English: Anti-gout treatments Colchicine
Croatian: Lijekovi za giht Kolhicin
English: However, since the renal clearance of ritonavir is negligible, no changes in the total body clearance are expected in patients with renal impairment.
Croatian: No budući da je klirens bubrega za ritonavir zanemarivo malen, ne očekuju se promjene ukupnog tjelesnog klirensa u bolesnika s oslabljenom funkcijom bubrega.
English: Ergot derivatives Dihydroergotamine, ergonovine, ergotamine, methylergonovine
Croatian: Derivati ergota Dihidroergotamin, ergonovin, ergotamin, metilergonovin
English: For specific information regarding the impact of co-administration of acid reducing agents, refer to the Summary of Product Characteristics of the co-administered protease inhibitor.
Croatian: Za specifične informacije o utjecaju istodobne primjene pripravaka koji smanjuju kiselost vidjeti Sažetak opisa svojstava lijeka za inhibitor proteaze koji se istodobno daje.
English: Thereby, increasing the risk of serious haematologic abnormalities, or other serious adverse effects from these agents.
Croatian: Time se povećava rizik od ozbiljnih hematoloških poremećaja i od ostalih ozbiljnih nuspojava tih lijekova.
English: Medicinal Products within Class
Croatian: Skupina lijekova Lijek unutar skupine
English: The renal clearance of ritonavir is negligible therefore; a decrease in the total body clearance is not expected in patients with renal impairment.
Croatian: Klirens bubrega za ritonavir je zanemarivo malen te se ne očekuje smanjenje ukupnog tjelesnog klirensa u bolesnika s oslabljenom funkcijom bubrega.
English: Divalproex, lamotrigine, phenytoin Ritonavir dosed as a pharmacokinetic enhancer or as an antiretroviral agent induces oxidation by CYP2C9 and glucuronidation and as a result is expected to decrease the plasma concentrations of anticonvulsants.
Croatian: Ritonavir doziran kao antiretrovirusni lijek ili kao farmakokinetički pojačivač inducira oksidaciju posredovanu enzimom CYP2C9 i glukuronidaciju, zbog čega se očekuje smanjenje koncentracije antikonvulziva u plazmi.
English: Ritonavir dosed as a pharmacokinetic enhancer The interaction profiles of HIV-protease inhibitors, co-administered with low dose ritonavir, are dependent on the specific co-administered protease inhibitor.
Croatian: Profil interakcija inhibitora HIV-proteaza, kada se daju istodobno s ritonavirom u malim dozama, ovisi o određenom inhibitoru proteaza koji se daje.
English: Arthralgia and back pain Myositis, rhabdomyolysis, myalgia, myopathy/CPK increased
Croatian: Miozitis, rabdomioliza, mialgija, miopatija/povišenje CK
English: Concomitant use of vardenafil with ritonavir is contraindicated (see section 4.3).
Croatian: Istodobna primjena vardenafila sa ritonavirom je kontraindicirana (vidjeti dio 4.3)
English: It is not recommended to co-administer ritonavir with simeprevir.
Croatian: Istodobna primjena ritonavira i simeprevira se ne preporučuje.
English: Ritonavir effects on non-antiretroviral co-administered medicinal products
Croatian: Učinci ritonavira na istodobno primijenjene lijekove koji nisu antiretrovirotici
English: • diabetes
Croatian: • šećerna bolest
English: Darunavir 800 mg once daily with ritonavir 100 mg once daily in ART-naïve patients.
Croatian: Darunavir 800 mg jedanput na dan s ritonavirom 100 mg jedanput na dan bolesnicima koji još nisu primali ART.
English: 400 q12 h Indinavir3 Ritonavir
Croatian: 400 svakih 12 h 400 svakih 12 h Indinavir3
English: However, since the renal clearance of ritonavir is negligible, the decrease in the total body clearance is not expected in patients with renal impairment.
Croatian: No budući da je klirens bubrega za ritonavir zanemarivo malen, ne očekuje se smanjenje ukupnog tjelesnog klirensa u bolesnika s oslabljenom funkcijom bubrega.
English: Darunavir 600 mg twice daily with ritonavir 100 mg twice daily in antiretroviral treatment.
Croatian: Darunavir 600 mg dva puta na dan s ritonavirom 100 mg dva puta na dan u bolesnika koji su već primali antiretrovirusnu terapiju (ART).
English: This is due to the induction of medicinal product metabolising enzymes by St John's wort.
Croatian: To se događa zato što gospina trava inducira enzime koji metaboliziraju lijek.
English: Serum concentrations may be increased due to CYP3A inhibition by ritonavir.
Croatian: Serumske se koncentracije mogu povećati zbog inhibicijskog učinka ritonavira na CYP3A.
English: Sorbitan laurate Silica, colloidal anhydrous Sodium chloride Sodium stearyl fumarate
Croatian: Tableta kopovidon sorbitanlaurat silicijev dioksid, koloidni, bezvodni natrijev klorid natrijev stearilfumarat
English: Ritonavir dosed as a pharmacokinetic enhancer or as an antiretroviral agent inhibits CYP3A4 and as a result is expected to increase the plasma concentrations of cyclosporine, tacrolimus or everolimus.
Croatian: Ritonavir doziran kao farmakokinetički pojačivač ili kao antiretrovirusni lijek inhibira CYP3A4, zbog čega se očekuje povećanje koncentracije ciklosporina, takrolimusa i everolimusa u plazmi.
English: Increased plasma concentrations of sildenafil.
Croatian: Povećane koncentracije sildenafila u plazmi.
English: Serum concentrations may be increased due to CYP3A and P-gp inhibition by ritonavir.
Croatian: Serumske se koncentracije mogu povećati zbog inhibicijskog učinka ritonavira na CYP3A i P-gp.
English: Doses of ritonavir higher than 100 mg twice daily should not be used.
Croatian: Ritonavir se ne smije davati u dozama većima od 100 mg dva puta na dan.
English: What Ritonavir Mylan is and what it is used for What you need to know before you or your child takes Ritonavir Mylan How to take Ritonavir Mylan
Croatian: Što morate znate prije nego što Vi ili Vaše dijete počnete uzimati Ritonavir Mylan Kako uzimati Ritonavir Mylan
English: 400 q12 h Saquinavir4 Ritonavir
Croatian: Ritonavir 400 svakih 12 h 400 svakih 12 h Sakvinavir
English: You may also notice irregular uterine bleeding if you are taking this type of hormonal contraceptive with ritonavir.
Croatian: Uzimate li tu vrstu hormonskog kontraceptiva i ritonavir, možda primijetite da je i menstrualno krvarenje postalo neredovito.
English: amphetamine or amphetamine derivatives; antibiotics (e.g. erythromycin, clarithromycin); anticancer treatments (e.g. abemaciclib, afatinib, ceritinib, dasatinib, ibrutinib, nilotinib, venetoclax, vincristine, vinblastine); anticoagulants (e.g. rivaroxaban, vorapaxar, warfarin); antidepressants (e.g. amitriptyline, desipramine, fluoxetine, imipramine, nefazodone, nortriptyline, paroxetine, sertraline, trazodone); antifungals (e.g. ketoconazole, itraconazole); antihistamines (e.g. loratadine, fexofenadine); antiretroviral medicines including HIV-protease inhibitors (amprenavir, atazanavir, darunavir, fosamprenavir, indinavir, nelfinavir, saquinavir, tipranavir) non-nucleoside reverse transcriptase inhibitors (NNRTI) (delavirdine, efavirenz, nevirapine), and others (didanosine, maraviroc, raltegravir, zidovudine); anti-tuberculosis medicine (bedaquiline and delamanid); antiviral medicine used to treat chronic hepatitis C virus (HCV) infection in adults (e.g. glecaprevir/pibrentasvir and simeprevir); anxiety medicine, buspirone; asthma medicine, theophylline, salmeterol; atovaquone, a medicine used to treat a certain type of pneumonia and malaria; buprenorphine, a medicine used for the treatment of chronic pain; bupropion, a medicine used to help you stop smoking; epilepsy medicines (e.g. carbamazepine, divalproex, lamotrigine, phenytoin); heart medicines (e.g. disopyramide, mexiletine and calcium channel antagonists such as amlodipine, diltiazem and nifedipine); immune system (e.g. cyclosporine, tacrolimus, everolimus); levothyroxine (used to treat thyroid problems)
Croatian: glecaprevir/pibrentasvir i simeprevir); - lijek za tjeskobu, buspiron; - lijekove za astmu, teofilin, salmeterol; - atovakon, lijek koji se koristi za liječenje određenih vrsta upale pluća i malarije; - buprenorfin, koji se koristi za liječenje kronične boli; - bupropion, koji se koristi za odvikavanje od pušenja; - lijekove za epilepsiju (npr. karbamazepin, divalproeks, lamotrigin, fenitoin); - lijekove za srce (npr. dizopiramid, meksiletin i antagonisti kalcijevih kanala, poput amlodipina,
English: Hepatic transaminase elevations exceeding five times the upper limit or normal, clinical hepatitis, and jaundice have occurred in patients receiving ritonavir alone or in combination with other antiretrovirals.
Croatian: U bolesnika koji su uzimali ritonavir sam ili u kombinaciji s drugim antiretroviroticima, zabilježena su povišenja vrijednosti jetrenih transaminaza više nego peterostruko od gornje granice normale, hepatitis i žutica.
English: Serum concentrations may be increased due to CYP3A4 inhibition by ritonavir.
Croatian: Serumske se koncentracije mogu povećati zbog inhibicijskog učinka ritonavira na CYP3A4.
English: ↑ 2 fold
Croatian: Gospina trava
English: Desipramine
Croatian: Apsorpcija
English: Pharyngitis, oropharyngeal pain, cough
Croatian: Vrlo često Faringitis, orofaringalna bol, kašalj
English: 600 q12 h Delavirdine1
Croatian: 400 svakih 8 h 600 svakih 12 h Delavirdin
English: HMG Co-A reductase inhibitors
Croatian: Lijekovi koji modificiraju lipide Inhibitori HMG Co-A reduktaze
English: Due to CYP3A inhibition by ritonavir, concentrations of lurasidone are expected to increase.
Croatian: Zbog inhibicije CYP3A ritonavirom, očekuje se povećanje koncentracija lurasidona.
English: A history of liver disease.
Croatian: - Preboljelu bolest jetre.
English: 4.4 Special warnings and precautions for use Ritonavir is not a cure for HIV-1 infection or AIDS.
Croatian: Ritonavir nije lijek za izlječenje infekcije virusom HIV-1 ni AIDS-a.
English: ↑ 11 fold
Croatian: ↑ 13 puta
English: Ritonavir increases the serum levels of tipranavir as a result of CYP3A inhibition.
Croatian: Ritonavir povisuje serumske razine tipranavira zbog inhibicije CYP3A.
English: In HIV-infected patients with severe immune deficiency at the time of initiation of combination antiretroviral therapy (CART), an inflammatory reaction to asymptomatic or residual opportunistic infections may arise.
Croatian: CART, combination antiretroviral therapy) javiti upalna reakcija na asimptomatske ili rezidualne oportunističke infekcije.
English: Careful monitoring of therapeutic and adverse effects is recommended when dexamethasone is concomitantly administered with ritonavir.
Croatian: Preporučuje se pažljivo praćenje terapijskih učinaka i mogućih nuspojava kada se fentanil daje istodobno s ritonavirom.
English: Thereby, increasing the risk of serious arrhythmias from these agents.
Croatian: Time se povećava rizik od ozbiljnih aritmija izazvanih tim lijekovima.
English: Important information regarding medicinal product interactions when ritonavir is used a pharmacokinetic enhancer is also contained in the Summary of Product Characteristics of the co-administered protease inhibitor.
Croatian: Važne informacije o interakcijama s drugim lijekovima kada se ritonavir daje kao farmakokinetički pojačivač nalaze se i u Sažetku opisa svojstava lijeka za određeni inhibitor proteaza u kombinaciji s kojim se ritonavir daje.
English: Ritonavir increases the serum levels of darunavir as a result of CYP3A inhibition.
Croatian: Ritonavir povisuje serumske razine darunavira zbog inhibicije CYP3A.
English: 600 q12 h 2 h later
Croatian: 200 svakih 12 h 600 svakih 12 h 2 h kasnije
English: Ritonavir co-administration is likely to result in increased plasma concentrations of clozapine or pimozide and is therefore contraindicated (see section 4.3).
Croatian: Istodobno primijenjeni ritonavir vjerojatno povećava koncentracije klozapina ili pimozida u plazmi te je stoga kontraindiciran (vidjeti dio 4.3).
English: Due to CYP3A inhibition by ritonavir, concentrations of ranolazine are expected to increase.
Croatian: Zbog inhibicije CYP3A ritonavirom očekuje se povećanje koncentracija ranolazina.
English: In a healthy volunteer drug interaction study of delamanid 100 mg twice daily and lopinavir/ritonavir 400/100 mg twice daily for 14 days, the
Croatian: U ispitivanju interakcija delamanida u dozi od 100 mg dva puta na dan i lopinavira/ritonavira u dozi od 400/100 mg dva puta na dan tijekom 14 dana kod zdravih dobrovoljaca, izloženost metabolitu delamanida DM-6705 je bila povišena za 30%.
English: Ritonavir may modify P-glycoprotein mediated fexofenadine efflux when dosed as an antiretroviral agent or as a pharmacokinetic enhancer resulting in increased concentrations of fexofenadine.
Croatian: Ritonavir doziran kao antiretrovirusni lijek ili kao farmakokinetički pojačivač može modificirati istjecanje feksofenadina posredovan P-glikoproteinom, zbog čega će se povećati koncentracije feksofenadina.
English: Also read the list of medicines under ‘Other medicines and Ritonavir Mylan' for use with certain other medicines which require special care.
Croatian: Za informacije o uzimanju određenih drugih lijekova zbog kojih je nužan poseban oprez, molimo pogledajte i popis lijekova u dijelu „Drugi lijekovi i Ritonavir Mylan”.
English: Ritonavir co-administration is likely to result in increased plasma concentrations of alfuzosin and is therefore contraindicated (see section 4.3).
Croatian: Istodobno primijenjeni ritonavir vjerojatno bi povećao plazmatske koncentracije alfuzosina te je stoga kontraindiciran (vidjeti dio 4.3).
English: Ritonavir dosed as an antiretroviral agent is likely to inhibit CYP2D6 and as a result is expected to increase concentrations of haloperidol, risperidone and thioridazine.
Croatian: Ritonavir doziran kao farmakokinetički pojačivač ili kao antiretrovirusni lijek vjerojatno inhibira CYP2D6, zbog čega se očekuje povećanje koncentracije haloperidola, risperidona i tioridazina.
English: 100 q12 h 500 q12 h
Croatian: 500 svakih 12 h 200 svakih 12 h Tipranavir
English: Due to CYP3A inhibition by ritonavir, concentrations of quetiapine are expected to increase.
Croatian: Zbog inhibicije CYP3A ritonavirom, očekuje se povećanje koncentracija kvetiapina.
English: For further information, refer to the Summary of Product Characteristics for darunavir.
Croatian: Daljnje informacije liječnik treba potražiti u Sažetku opisa svojstava lijeka za darunavir.
English: 300 q24 h
Croatian: 300 svakih 24 h 100 svakih 24h Atazanavir
English: Only when atazanavir with ritonavir is co-administered with efavirenz, a dose increase of ritonavir to 200 mg once daily could be considered.
Croatian: Povećanje doze ritonavira na 200 mg jedanput na dan može se razmotriti samo ako se uz atazanavir i ritonavir istodobno daje i efavirenz.
English: Ritonavir co-administration is likely to result in increased plasma concentrations of both fusidic acid and ritonavir and is therefore contraindicated (see section 4.3).
Croatian: Istodobno primijenjeni ritonavir vjerojatno povećava koncentracije i fuzidične kiseline i ritonavira u plazmi te je stoga kontraindiciran (vidjeti dio 4.3).